Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 212

1.

A comparison of the effectiveness of zanamivir and oseltamivir for the treatment of influenza A and B.

Kawai N, Ikematsu H, Iwaki N, Maeda T, Kanazawa H, Kawashima T, Tanaka O, Yamauchi S, Kawamura K, Nagai T, Horii S, Hirotsu N, Kashiwagi S.

J Infect. 2008 Jan;56(1):51-7. Epub 2007 Oct 15.

PMID:
17936910
2.

Clinical effectiveness of oseltamivir and zanamivir for treatment of influenza A virus subtype H1N1 with the H274Y mutation: a Japanese, multicenter study of the 2007-2008 and 2008-2009 influenza seasons.

Kawai N, Ikematsu H, Hirotsu N, Maeda T, Kawashima T, Tanaka O, Yamauchi S, Kawamura K, Matsuura S, Nishimura M, Iwaki N, Kashiwagi S.

Clin Infect Dis. 2009 Dec 15;49(12):1828-35. doi: 10.1086/648424.

3.

Comparison of the clinical effectiveness of oseltamivir and zanamivir against influenza virus infection in children.

Sugaya N, Tamura D, Yamazaki M, Ichikawa M, Kawakami C, Kawaoka Y, Mitamura K.

Clin Infect Dis. 2008 Aug 1;47(3):339-45. doi: 10.1086/589748.

4.

A comparison of the effectiveness of oseltamivir for the treatment of influenza A and influenza B: a Japanese multicenter study of the 2003-2004 and 2004-2005 influenza seasons.

Kawai N, Ikematsu H, Iwaki N, Maeda T, Satoh I, Hirotsu N, Kashiwagi S.

Clin Infect Dis. 2006 Aug 15;43(4):439-44. Epub 2006 Jun 26.

5.

Factors influencing the effectiveness of oseltamivir and amantadine for the treatment of influenza: a multicenter study from Japan of the 2002-2003 influenza season.

Kawai N, Ikematsu H, Iwaki N, Satoh I, Kawashima T, Maeda T, Miyachi K, Hirotsu N, Shigematsu T, Kashiwagi S.

Clin Infect Dis. 2005 May 1;40(9):1309-16. Epub 2005 Mar 16.

6.

Effectiveness of oseltamivir treatment among children with influenza A or B virus infections during four successive winters in Niigata City, Japan.

Sato M, Saito R, Sato I, Tanabe N, Shobugawa Y, Sasaki A, Li D, Suzuki Y, Sato M, Sakai T, Oguma T, Tsukada H, Gejyo F, Suzuki H.

Tohoku J Exp Med. 2008 Feb;214(2):113-20.

7.

Comparison of the effectiveness of Zanamivir and Oseltamivir against influenza A/H1N1, A/H3N2, and B.

Kawai N, Ikematsu H, Iwaki N, Maeda T, Kawashima T, Hirotsu N, Kashiwagi S.

Clin Infect Dis. 2009 Apr 1;48(7):996-7. doi: 10.1086/597360. No abstract available.

8.

The course of fever following influenza virus infection in children treated with oseltamivir.

Suzuki E, Ichihara K.

J Med Virol. 2008 Jun;80(6):1065-71. doi: 10.1002/jmv.21144.

PMID:
18428131
9.

Longer virus shedding in influenza B than in influenza A among outpatients treated with oseltamivir.

Kawai N, Ikematsu H, Iwaki N, Kawashima T, Maeda T, Mitsuoka S, Kondou K, Satoh I, Miyachi K, Yamaga S, Shigematsu T, Hirotsu N, Kashiwagi S.

J Infect. 2007 Sep;55(3):267-72. Epub 2007 Jul 2.

PMID:
17604839
10.

Utility of Maoto in an influenza season where reduced effectiveness of oseltamivir was observed - a clinical, non-randomized study in children.

Toriumi Y, Kamei T, Murata K, Takahashi I, Suzuki N, Mazda O.

Forsch Komplementmed. 2012;19(4):179-86. doi: 10.1159/000341547. Epub 2012 Aug 20.

PMID:
22964983
11.

A change in the effectiveness of amantadine for the treatment of influenza over the 2003-2004, 2004-2005, and 2005-2006 influenza seasons in Japan.

Kawai N, Ikematsu H, Iwaki N, Kawamura K, Kawashima T, Kashiwagi S.

J Infect Chemother. 2007 Oct;13(5):314-9. Epub 2007 Oct 30.

PMID:
17982720
12.

Zanamivir treatment is equally effective for both influenza A and influenza B.

Kawai N, Ikematsu H, Iwaki N, Tanaka O, Yamanishi Y, Hirotsu N, Kashiwagi S.

Clin Infect Dis. 2007 Jun 15;44(12):1666. No abstract available.

13.

Antipyretic effect of Mao-to, a Japanese herbal medicine, for treatment of type A influenza infection in children.

Kubo T, Nishimura H.

Phytomedicine. 2007 Feb;14(2-3):96-101. Epub 2006 Dec 1.

PMID:
17141491
14.

Early administration of oral oseltamivir increases the benefits of influenza treatment.

Aoki FY, Macleod MD, Paggiaro P, Carewicz O, El Sawy A, Wat C, Griffiths M, Waalberg E, Ward P; IMPACT Study Group.

J Antimicrob Chemother. 2003 Jan;51(1):123-9.

15.

[Neuraminidase inhibitors and risk of H5N1 influenza].

Gras-Masse H, Willand N.

Ann Pharm Fr. 2007 Jan;65(1):50-7. Review. French.

PMID:
17299351
16.

Long-acting neuraminidase inhibitor laninamivir octanoate versus oseltamivir for treatment of influenza: A double-blind, randomized, noninferiority clinical trial.

Watanabe A, Chang SC, Kim MJ, Chu DW, Ohashi Y; MARVEL Study Group.

Clin Infect Dis. 2010 Nov 15;51(10):1167-75. doi: 10.1086/656802. Epub 2010 Oct 11.

17.

Zanamivir for treatment of symptomatic influenza A and B infection in children five to twelve years of age: a randomized controlled trial.

Hedrick JA, Barzilai A, Behre U, Henderson FW, Hammond J, Reilly L, Keene O.

Pediatr Infect Dis J. 2000 May;19(5):410-7.

PMID:
10819336
18.

Failure of combination oral oseltamivir and inhaled zanamivir antiviral treatment in ventilator- and ECMO-treated critically ill patients with pandemic influenza A (H1N1)v.

Petersen E, Keld DB, Ellermann-Eriksen S, Gubbels S, Ilkjær S, Jensen-Fangel S, Lindskov C.

Scand J Infect Dis. 2011 Jul;43(6-7):495-503. doi: 10.3109/00365548.2011.556144. Epub 2011 Feb 10.

PMID:
21309638
19.

Increased symptom severity but unchanged neuraminidase inhibitor effectiveness for A(H1N1)pdm09 in the 2010-2011 season: comparison with the previous season and with seasonal A(H3N2) and B.

Kawai N, Ikematsu H, Kawashima T, Maeda T, Ukai H, Hirotsu N, Iwaki N, Kashiwagi S.

Influenza Other Respir Viruses. 2013 May;7(3):448-55. doi: 10.1111/j.1750-2659.2012.00421.x. Epub 2012 Aug 16.

20.

Lower clinical effectiveness of oseltamivir against influenza B contrasted with influenza A infection in children.

Sugaya N, Mitamura K, Yamazaki M, Tamura D, Ichikawa M, Kimura K, Kawakami C, Kiso M, Ito M, Hatakeyama S, Kawaoka Y.

Clin Infect Dis. 2007 Jan 15;44(2):197-202. Epub 2006 Dec 14.

Items per page

Supplemental Content

Write to the Help Desk